Dwyer KM - Search Results

1

The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes.

Chia JS, McRae JL, Cowan PJ, Dwyer KM. Chia JS, et al. Among authors: dwyer km. J Biomed Biotechnol. 2012;2012:320495. doi: 10.1155/2012/320495. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23118504 Free PMC article. Review.

2

Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.

Pommey S, Lu B, McRae J, Stagg J, Hill P, Salvaris E, Robson SC, d'Apice AJ, Cowan PJ, Dwyer KM. Pommey S, et al. Among authors: dwyer km. Hepatology. 2013 Apr;57(4):1597-606. doi: 10.1002/hep.25985. Epub 2013 Mar 14. Hepatology. 2013. PMID: 22829222

3

The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.

Roberts V, Lu B, Rajakumar S, Cowan PJ, Dwyer KM. Roberts V, et al. Among authors: dwyer km. Purinergic Signal. 2013 Jun;9(2):135-43. doi: 10.1007/s11302-012-9342-3. Epub 2012 Nov 29. Purinergic Signal. 2013. PMID: 23188420 Free PMC article. Review.

4

The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice.

Chia JS, McRae JL, Thomas HE, Fynch S, Elkerbout L, Hill P, Murray-Segal L, Robson SC, Chen JF, d'Apice AJ, Cowan PJ, Dwyer KM. Chia JS, et al. Among authors: dwyer km. Diabetes. 2013 Jun;62(6):2026-35. doi: 10.2337/db12-0625. Epub 2013 Jan 30. Diabetes. 2013. PMID: 23364452 Free PMC article.

5

Overexpression of CD39 protects in a mouse model of preeclampsia.

McRae JL, Russell PA, Chia JS, Dwyer KM. McRae JL, et al. Among authors: dwyer km. Nephrology (Carlton). 2013 May;18(5):351-5. doi: 10.1111/nep.12058. Nephrology (Carlton). 2013. PMID: 23600369

6

Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.

Covarrubias R, Chepurko E, Reynolds A, Huttinger ZM, Huttinger R, Stanfill K, Wheeler DG, Novitskaya T, Robson SC, Dwyer KM, Cowan PJ, Gumina RJ. Covarrubias R, et al. Among authors: dwyer km. Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1809-20. doi: 10.1161/ATVBAHA.116.307374. Epub 2016 Jul 14. Arterioscler Thromb Vasc Biol. 2016. PMID: 27417582 Free PMC article.

7

CD39 overexpression does not attenuate renal fibrosis in the unilateral ureteric obstructive model of chronic kidney disease.

Roberts V, Lu B, Chia J, Cowan PJ, Dwyer KM. Roberts V, et al. Among authors: dwyer km. Purinergic Signal. 2016 Dec;12(4):653-660. doi: 10.1007/s11302-016-9528-1. Epub 2016 Aug 26. Purinergic Signal. 2016. PMID: 27565966 Free PMC article.

8

Evaluation of CD4⁺ CD25^+/- CD39⁺ T-cell populations in peripheral blood of patients following kidney transplantation and during acute allograft rejection.

McRae JL, Chia JS, Pommey SA, Dwyer KM. McRae JL, et al. Among authors: dwyer km. Nephrology (Carlton). 2017 Jul;22(7):505-512. doi: 10.1111/nep.12894. Nephrology (Carlton). 2017. PMID: 27517975

9

The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.

Roberts V, Campbell DJ, Lu B, Chia J, Cowan PJ, Dwyer KM. Roberts V, et al. Among authors: dwyer km. Transplantation. 2017 Jul;101(7):e194-e204. doi: 10.1097/TP.0000000000001679. Transplantation. 2017. PMID: 28198766

10

Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.

Sashindranath M, Dwyer KM, Dezfouli S, Selan C, Crikis S, Lu B, Yuan Y, Hickey MJ, Peter K, Robson SC, Cowan PJ, Nandurkar HH. Sashindranath M, et al. Among authors: dwyer km. Purinergic Signal. 2017 Jun;13(2):259-265. doi: 10.1007/s11302-017-9558-3. Epub 2017 Mar 25. Purinergic Signal. 2017. PMID: 28343356 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page